COMPANY

Kathera Bioscience Inc.

Keywords: fungal infections

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $995K (SBIR Phase II 5R44AI181163-03, continuation, notice May 25, 2026). NIH RePORTER 5R44AI181163-03 (May 25, 2026)
Evidence (1 event)
- May 25, 2026 · NIH RePORTER 5R44AI181163-03
  Organization: KATHERA BIOSCIENCE INC.; City/State: UNION, NJ; Project number: 5R44AI181163-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-05-25; FY total cost (award amount): 995100; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Novel Broad Spectrum Inhibitors of Dihydrofolate Reductase (DHFR) for Treatment of Infections from High Threat Fungal Pathogens; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

May 25, 2026 Grant Government grant — SBIR: $995,100 (annual award, as published), announced May 25, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 4, 2025 Grant Government grant — SBIR: $995,100 (annual award, as published), announced Jun 4, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Last 2 years.

May 25, 2026 Government grant — SBIR: $995,100 (annual award, as published), announced May 25, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jun 4, 2025 Government grant — SBIR: $995,100 (annual award, as published), announced Jun 4, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Annual award amounts. Total $1.2M.

Jul 31, 2024 NIH award 5R43AI170288-02 FY2024: $298,530 awarded for that fiscal year; activity R43 (SBIR); PI PARENT, STEPHEN; recipient as written: KATHERA BIOSCIENCE INC., UNION, NJ. A Redesigning Existing Drugs against Indispe source ↗
Jan 2, 2024 NIH award 1R44AI181163-01 FY2024: $298,530 awarded for that fiscal year; activity R44 (SBIR); PI PARENT, STEPHEN; recipient as written: KATHERA BIOSCIENCE INC., UNION, NJ. Novel Broad Spectrum Inhibitors of Dihydrofo source ↗
Aug 11, 2023 NIH award 1R43AI170288-01A1 FY2023: $298,530 awarded for that fiscal year; activity R43 (SBIR); PI PARENT, STEPHEN; recipient as written: KATHERA BIOSCIENCE INC., UNION, NJ. A Redesigning Existing Drugs against Indis source ↗
Jun 17, 2021 NIH award 1R43AI162468-01A1 FY2021: $298,530 awarded for that fiscal year; activity R43 (SBIR); PI PARENT, STEPHEN; recipient as written: KATHERA BIOSCIENCE INC., UNION, NJ. Ess1: A pathogenic fungal target for a nov source ↗